SKI Market

Indian Indices

Sensex

82,917.54 -757.38
( -0.91%)

Global Indices

Nasdaq

49,462.85 -679.56
(-1.36%)

Dow Jones

6,851.97 -110.50
(-1.59%)

Hang Seng

57,686.98 36.44
(0.06%)

Nikkei 225

10,413.72 -58.39
(-0.56%)

Forex

USD-INR

90.66 0.06
(0.07%)

EUR-INR

107.82 -0.02
(-0.02%)

GBP-INR

123.81 -0.01
(0.00%)

JPY-INR

0.59 0.01
(1.13%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nath Bio-Genes (India) Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

537291

INE448G01010

361.6466007

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATHBIOGEN

5.76

284.39

EPS(TTM)

Face Value()

Div & Yield %

25.97

1.34

Back

Assam Entrade reports consolidated net loss of Rs 0.01 crore in the September 2025 quarter

Nov 13,2025

Net loss of Assam Entrade reported to Rs 0.01 crore in the quarter ended September 2025 as against net profit of Rs 1.72 crore during the previous quarter ended September 2024. Sales declined 16.32% to Rs 2.00 crore in the quarter ended September 2025 as against Rs 2.39 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2.00	2.39	-16
OPM %	3.50	-77.82	-
PBDT	0.01	2.32	-100
PBT	-0.01	2.30	PL
NP	-0.01	1.72	PL

82,917.54 -757.38 ( -0.91%)

49,462.85 -679.56 (-1.36%)

6,851.97 -110.50 (-1.59%)

57,686.98 36.44 (0.06%)

10,413.72 -58.39 (-0.56%)

90.66 0.06 (0.07%)

107.82 -0.02 (-0.02%)

123.81 -0.01 (0.00%)

0.59 0.01 (1.13%)